A novel approach to safer glucocorticoid receptor–targeted anti-lymphoma therapy via REDD1 (regulated in development and DNA damage 1) inhibition

Ekaterina A. Lesovaya, Alena V. Savinkova, Olga V. Morozova, Evgeniya S. Lylova, Ekaterina M. Zhidkova, Evgeny P. Kulikov, Kirill I. Kirsanov, Anna Klopot, Gleb Baida, Marianna G. Yakubovskaya, Leo I. Gordon, Ben Readhead, Joel T. Dudley, Irina Budunova

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A novel approach to safer glucocorticoid receptor–targeted anti-lymphoma therapy via REDD1 (regulated in development and DNA damage 1) inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences